| Development of a downstream process for the production of an inactivated whole hepatitis C virus vaccine K Lothert, AF Offersgaard, AF Pihl, CK Mathiesen, TB Jensen, GP Alzua, ... Scientific Reports 10 (1), 16261, 2020 | 31 | 2020 |
| Membrane-based steric exclusion chromatography for the purification of a recombinant baculovirus and its application for cell therapy K Lothert, G Sprick, F Beyer, G Lauria, P Czermak, MW Wolff Journal of virological methods 275, 113756, 2020 | 31 | 2020 |
| Selection of chromatographic methods for the purification of cell culture-derived Orf virus for its application as a vaccine or viral vector K Lothert, F Pagallies, T Feger, R Amann, MW Wolff Journal of biotechnology 323, 62-72, 2020 | 26 | 2020 |
| A scalable downstream process for the purification of the cell culture-derived Orf virus for human or veterinary applications K Lothert, F Pagallies, F Eilts, A Sivanesapillai, M Hardt, A Moebus, ... Journal of Biotechnology 323, 221-230, 2020 | 24 | 2020 |
| Purification of new biologicals using membrane-based processes D Hoffmann, J Leber, D Loewe, K Lothert, T Oppermann, J Zitzmann, ... Current trends and future developments on (bio-) membranes, 123-150, 2019 | 16 | 2019 |
| Quantification methods for viruses and virus-like particles applied in biopharmaceutical production processes K Lothert, F Eilts, MW Wolff Expert review of vaccines 21 (8), 1029-1044, 2022 | 15 | 2022 |
| A summary of practical considerations for the application of the steric exclusion chromatography for the purification of the Orf viral vector F Eilts, K Lothert, S Orbay, F Pagallies, R Amann, MW Wolff Membranes 12 (11), 1070, 2022 | 7 | 2022 |
| The suitability of latex particles to evaluate critical process parameters in steric exclusion chromatography F Eilts, M Steger, K Lothert, MW Wolff Membranes 12 (5), 488, 2022 | 6 | 2022 |
| Upstream and downstream processes for viral nanoplexes as vaccines K Lothert, G Dekevic, D Loewe, D Salzig, P Czermak, MW Wolff Vaccine Delivery Technology: Methods and Protocols, 217-248, 2021 | 6 | 2021 |
| Affinity and Pseudo-Affinity Membrane Chromatography for Viral Vector and Vaccine Purifications: A Review K Lothert, MW Wolff Membranes 13 (9), 770, 2023 | 3 | 2023 |
| Evaluation of restricted access media for the purification of cell culture‐derived Orf viruses K Lothert, YMJ Harsy, P Endres, E Müller, MW Wolff Engineering in Life Sciences 23 (9), e2300009, 2023 | 2 | 2023 |
| Steric exclusion chromatography: Advancement of a laboratory-based platform technology into a key component of viral vector and vaccine production processes K Lothert | 2 | 2021 |
| An investigation of excipients for a stable Orf viral vector formulation F Eilts, YMJ Harsy, K Lothert, F Pagallies, R Amann, MW Wolff Virus Research 336, 199213, 2023 | 1 | 2023 |
| Chromatographic Purification of Viruses: State of the Art and Current Trends K Lothert, MW Wolff Bioprocess and Analytics Development for Virus-based Advanced Therapeutics …, 2023 | 1 | 2023 |
| Evaluation of Novel Quantification Approaches for Infectious Viruses K Lothert, E Bagrin, MW Wolff 2023 AIChE Annual Meeting, 2023 | | 2023 |
| Development of a Cell Culture-Derived Viral Insecticide to Control the Spread of Drosophila Suzukii K Lothert, Y Harsy, T Gröb, KZ Lee, MW Wolff 2023 AIChE Annual Meeting, 2023 | | 2023 |
| Method of purifying whole virus particles JM Gottwein, J Bukh, A Offersgaard, AF Pihl, M Wolff, K Lothert US Patent App. 18/016,150, 2023 | | 2023 |
| Evaluating Novel Quantification Methods for Infectious Baculoviruses K Lothert, E Bagrin, MW Wolff Viruses 15 (4), 998, 2023 | | 2023 |
| Method of purifying whole virus particles JM Gottwein, J Bukh, A OFFERSGAARD, AF PIHL, M Wolff, K Lothert | | 2022 |
| Single-use purification of cell culture-based virus particles by steric exclusion chromatography P Marichal-Gallardo, K Lothert, T Grein, U Reichl, P Czermak, MW Wolff National Meeting of the American Chemical Society (ACS), 2018 | | 2018 |
